Qiagen (QGEN) Stock Price Target 2026

The average analyst price target for Qiagen is $47.22, 6.6% below the current price. Of 14 analysts, 7 rate it Buy and 7 Hold. Targets range from $36 to $54. The latest change came on Oct 28, 2026, when Barclays downgraded Qiagen from Overweight to Equal-Weight and moved its price target from $55 to $53.

The Average Analyst Price Target for Qiagen is $47.22.

Price Target Range — 13 Quarters

Analyst Consensus — 14 Analysts

7Buy

7Hold

Consensus RatingNeutral# Analysts14Avg. Consensus PT$47.22Upside to Avg. PT-6.6%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Qiagen Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 28, 2026	Barclays	Luke Sergott	Downgrade	Overweight→Equal-Weight	$55→$53
Oct 26, 2026	Citigroup	Albert Hu	PT Raise	Neutral	$45→$52
Oct 22, 2026	JP Morgan	Casey Woodring	Downgrade	Overweight→Neutral	$55→$52
Oct 22, 2026	Baird	Catherine Schulte	PT Raise	Outperform	$50→$52
Oct 14, 2026	JP Morgan	Casey Woodring	PT Raise	Overweight	$50→$55
Oct 6, 2026	Barclays	Luke Sergott	Upgrade	Equal-Weight→Overweight	$40→$55
Sep 9, 2026	UBS	Dan Leonard	PT Cut	Neutral	$52→$47
Aug 10, 2026	Citigroup	Brendan Digan	PT Raise	Neutral	$38→$45
Aug 7, 2026	Barclays	Luke Sergott	PT Raise	Equal-Weight	$38→$40
Aug 7, 2026	JP Morgan	Casey Woodring	PT Raise	Overweight	$45→$50
Jun 23, 2026	Morgan Stanley	Steve Beuchaw	Upgrade	Equal-Weight→Overweight	$40→$42
May 18, 2026	Stifel	Daniel Arias	PT Cut	Hold	$50→$36
May 7, 2026	TD Cowen	Dan Brennan	PT Cut	Hold	$46→$40
Apr 29, 2026	JP Morgan	Casey Woodring	PT Cut	Overweight	$60→$45
Apr 29, 2026	Citigroup	Patrick Donnelly	PT Cut	Neutral	$55→$38
Apr 29, 2026	Barclays	Luke Sergott	PT Cut	Equal-Weight	$44→$38
Apr 29, 2026	Baird	Catherine Schulte	Upgrade	Neutral→Outperform	$53→$43
Apr 14, 2026	Barclays	Luke Sergott	Downgrade	Overweight→Equal-Weight	$44
Mar 13, 2026	Deutsche Bank	Jan Koch	Upgrade	Hold→Buy	$54
Feb 6, 2026	JP Morgan	Casey Woodring	PT Raise	Overweight	$55→$60